Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development - Concepedia

Concepedia

Publication | Closed Access

Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development

39

Citations

14

References

2018

Year

Kristell Lebozec, Martine Jandrot‐Perrus, Gilles Avenard, Olivier Favre‐Bulle, Philippe Billiald

New Biotechnology

Recombinant Antibody FragmentPharmaceutical DevelopmentCost AssessmentImmunologyBiotechnologyAntibody ScreeningImmunochemistryAntibody EngineeringImmunotherapyMedicinePharmaceutical Biotechnology

References

	Year	Citations

Page 1